LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1334	3325	3970	0.8374	0.7551
BT-20	Erlotinib	0.04	uM	LJP5	72	hr	1334	3679	3970	0.9267	0.8895
BT-20	Brivanib	0.04	uM	LJP5	72	hr	1334	4008	3970	1.0093	1.0141
BT-20	CP466722	0.04	uM	LJP5	72	hr	1334	4240	3970	1.0678	1.1022
BT-20	Dovitinib	0.04	uM	LJP5	72	hr	1334	3395	3970	0.8550	0.7815
BT-20	Enzastaurin	0.04	uM	LJP5	72	hr	1334	3740	3970	0.9419	0.9125
BT-20	Sigma A6730	0.04	uM	LJP5	72	hr	1334	3511	3970	0.8843	0.8257
BT-20	XMD16-144	0.04	uM	LJP5	72	hr	1334	3824	3970	0.9632	0.9445
BT-20	Buparlisib	0.04	uM	LJP5	72	hr	1334	4150	3970	1.0451	1.0679
BT-20	CP724714	0.04	uM	LJP5	72	hr	1334	3801	3970	0.9572	0.9356
BT-20	Momelotinib	0.04	uM	LJP5	72	hr	1334	3991	3970	1.0051	1.0077
BT-20	Dasatinib	0.04	uM	LJP5	72	hr	1334	3455	3970	0.8701	0.8043
BT-20	GDC-0980	0.04	uM	LJP5	72	hr	1334	2403	3970	0.6052	0.4054
BT-20	NVP-AEW541	0.04	uM	LJP5	72	hr	1334	4135	3970	1.0415	1.0625
BT-20	SB590885	0.04	uM	LJP5	72	hr	1334	4237	3970	1.0671	1.1011
BT-20	PIK-93	0.04	uM	LJP5	72	hr	1334	4133	3970	1.0410	1.0617
BT-20	AZD8330	0.04	uM	LJP5	72	hr	1334	3067	3970	0.7725	0.6573
BT-20	Alpelisib	0.04	uM	LJP5	72	hr	1334	4126	3970	1.0391	1.0590
BT-20	Luminespib	0.04	uM	LJP5	72	hr	1334	980	3970	0.2469	-0.1344
BT-20	Barasertib	0.04	uM	LJP5	72	hr	1334	3344	3970	0.8423	0.7625
BT-20	BX-912	0.04	uM	LJP5	72	hr	1334	3739	3970	0.9417	0.9122
BT-20	CGP60474	0.04	uM	LJP5	72	hr	1334	3530	3970	0.8891	0.8329
BT-20	AZD-6482	0.04	uM	LJP5	72	hr	1334	4128	3970	1.0396	1.0596
BT-20	WH-4-025	0.04	uM	LJP5	72	hr	1334	3860	3970	0.9721	0.9579
BT-20	Foretinib	0.04	uM	LJP5	72	hr	1334	3950	3970	0.9948	0.9922

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)